4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-16-012633
Director bought 15,000 shares at an average $1.99 ($29,900)
From the SEC's structured data for this filing
Trades in this filing
SETH SANDESH · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-14 | Purchase : show line 1 in the form | +5,000 | $2.00 | $10,000 | 15,000 | D |
| 2016-04-15 | Purchase : show line 2 in the form | +2,000 | $2.00 | $4,000 | 17,000 | D |
| 2016-04-15 | Purchase : show line 3 in the form | +1,500 | $2.01 | $3,015 | 18,500 | D |
| 2016-04-18 | Purchase : show line 4 in the form | +5,000 | $1.98 | $9,900 | 23,500 | D |
| 2016-04-18 | Purchase : show line 5 in the form | +1,500 | $1.99 | $2,985 | 25,000 | D |
| Open-market purchases · 15,000 sh · avg $1.99 · $29,900 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-15 | Grant or award : show line 6 in the form Options to purchase common stock | +500,000 | $1.99 | $995,000 | 500,000 | D |
Loading xslF345X03/f4041416seth_actiniumpharm.xml…